StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) Receives EMA CHMP Approval for MDV Presentation of Prevenar 13
April 6, 2016 11:08 AM
Pfizer Inc. (NYSE: PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Management Comments
Next Articles
Pfizer (PFE) Pushes Higher after Ending Allergan Deal; Shares Cross Above 200 DMA
April 6, 2016 12:35 PM
Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®
April 6, 2016 11:00 AM